Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 393
5
Diseases
6
Unique genes
0.422
Avg. similarity score
Bethlem myopathy
Most-connected disease (4 links)
Disease
Searched: dystonia 27
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
dystonia 27
Bethlem myopathy
Collagen vi muscular dystrophy
Ullrich congenital muscular dystrophy
collagen 6-related myopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bethlem myopathy | 4 | 4 | 6 |
| Collagen vi muscular dystrophy | 4 | 4 | 3 |
| Ullrich congenital muscular dystrophy | 4 | 4 | 4 |
| collagen 6-related myopathy | 4 | 4 | 3 |
| dystonia 27 | 4 | 4 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL6A3 | 5 / 5 | Bethlem myopathy, collagen 6-related myopathy, Collagen vi muscular dystrophy, dystonia 27 and 1 more |
| COL6A1 | 4 / 5 | Bethlem myopathy, collagen 6-related myopathy, Collagen vi muscular dystrophy, Ullrich congenital muscular dystrophy |
| COL6A2 | 4 / 5 | Bethlem myopathy, collagen 6-related myopathy, Collagen vi muscular dystrophy, Ullrich congenital muscular dystrophy |
| COL12A1 | 2 / 5 | Bethlem myopathy, Ullrich congenital muscular dystrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Collagen chain trimerization | Reactome | 4 / 44 | 182× | 2.34e-9 | 2.50e-7 ✓ sig. |
| Assembly of collagen fibrils and other multimeric structures | Reactome | 4 / 51 | 157× | 4.30e-9 | 4.36e-7 ✓ sig. |
| Collagen degradation | Reactome | 4 / 52 | 154× | 4.66e-9 | 4.69e-7 ✓ sig. |
| Collagen biosynthesis and modifying enzymes | Reactome | 4 / 67 | 120× | 1.32e-8 | 1.16e-6 ✓ sig. |
| Protein digestion and absorption | KEGG | 4 / 103 | 77.7× | 7.55e-8 | 5.47e-6 ✓ sig. |
| NCAM1 interactions | Reactome | 3 / 21 | 286× | 9.18e-8 | 6.55e-6 ✓ sig. |
| Signaling by PDGF | Reactome | 3 / 33 | 182× | 3.76e-7 | 2.23e-5 ✓ sig. |
| ECM proteoglycans | Reactome | 3 / 51 | 118× | 1.43e-6 | 7.17e-5 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 4 / 232 | 34.5× | 1.97e-6 | 9.37e-5 ✓ sig. |
| Integrin cell surface interactions | Reactome | 3 / 81 | 74.1× | 5.83e-6 | 2.29e-4 ✓ sig. |
| ECM-receptor interaction | KEGG | 3 / 89 | 67.5× | 7.74e-6 | 2.89e-4 ✓ sig. |
| Focal adhesion | KEGG | 3 / 203 | 29.6× | 9.17e-5 | 2.16e-3 ✓ sig. |
| Human papillomavirus infection | KEGG | 3 / 333 | 18.0× | 3.97e-4 | 6.91e-3 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 3 / 361 | 16.6× | 5.03e-4 | 8.31e-3 ✓ sig. |
| Breakdown of the nuclear lamina | Reactome | 1 / 3 | 667× | 1.50e-3 | 1.92e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| muscle cell apoptotic process | GO:0010657 | 2 / 2 | 3,115× | 8.59e-8 | 1.08e-5 ✓ sig. |
| response to UV | GO:0009411 | 3 / 54 | 173× | 4.53e-7 | 4.42e-5 ✓ sig. |
| phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0043491 | 3 / 92 | 102× | 2.29e-6 | 1.66e-4 ✓ sig. |
| neuron apoptotic process | GO:0051402 | 3 / 98 | 95.3× | 2.77e-6 | 1.93e-4 ✓ sig. |
| muscle organ development | GO:0007517 | 3 / 114 | 82.0× | 4.36e-6 | 2.77e-4 ✓ sig. |
| cell adhesion | GO:0007155 | 4 / 665 | 18.7× | 2.25e-5 | 1.02e-3 ✓ sig. |
| nuclear envelope organization | GO:0006998 | 2 / 24 | 260× | 2.36e-5 | 1.05e-3 ✓ sig. |
| endodermal cell differentiation | GO:0035987 | 2 / 36 | 173× | 5.39e-5 | 1.97e-3 ✓ sig. |
| tissue development | GO:0009888 | 2 / 51 | 122× | 1.09e-4 | 3.33e-3 ✓ sig. |
| collagen fibril organization | GO:0030199 | 2 / 65 | 95.8× | 1.77e-4 | 4.78e-3 ✓ sig. |
| response to glucose | GO:0009749 | 2 / 68 | 91.6× | 1.94e-4 | 5.11e-3 ✓ sig. |
| response to polyamine macromolecule | GO:1904583 | 1 / 1 | 3,115× | 3.21e-4 | 7.28e-3 ✓ sig. |
| regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | GO:0014853 | 1 / 1 | 3,115× | 3.21e-4 | 7.28e-3 ✓ sig. |
| DNA double-strand break attachment to nuclear envelope | GO:1990683 | 1 / 2 | 1,557× | 6.42e-4 | 1.16e-2 ✓ sig. |
| multicellular organismal locomotion | GO:0071965 | 1 / 2 | 1,557× | 6.42e-4 | 1.16e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bethlem myopathy | Ullrich congenital muscular dystrophy | 0.571 | 4 | 6.41e-15 | 9.10e-14 ✓ sig. |
| collagen 6-related myopathy | Collagen vi muscular dystrophy | 0.750 | 3 | 1.64e-12 | 1.92e-11 ✓ sig. |
| collagen 6-related myopathy | Ullrich congenital muscular dystrophy | 0.600 | 3 | 6.58e-12 | 7.30e-11 ✓ sig. |
| Collagen vi muscular dystrophy | Ullrich congenital muscular dystrophy | 0.600 | 3 | 6.58e-12 | 7.30e-11 ✓ sig. |
| Bethlem myopathy | Collagen vi muscular dystrophy | 0.429 | 3 | 3.29e-11 | 3.41e-10 ✓ sig. |
| Bethlem myopathy | collagen 6-related myopathy | 0.429 | 3 | 3.29e-11 | 3.41e-10 ✓ sig. |
| collagen 6-related myopathy | dystonia 27 | 0.250 | 1 | 1.95e-4 | 5.35e-4 ✓ sig. |
| Collagen vi muscular dystrophy | dystonia 27 | 0.250 | 1 | 1.95e-4 | 5.35e-4 ✓ sig. |
| dystonia 27 | Ullrich congenital muscular dystrophy | 0.200 | 1 | 2.60e-4 | 6.51e-4 ✓ sig. |
| Bethlem myopathy | dystonia 27 | 0.143 | 1 | 3.90e-4 | 8.67e-4 ✓ sig. |